EUROCRINE®: adrenal surgery 2015–2019— surprising initial results

8Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Since 2015 operations performed in the field of endocrine surgery have been entered into the European registry EUROCRINE®. The aim of this analysis was a description of the current healthcare situation for adrenal surgery in a homogeneous healthcare environment corresponding to the German-speaking countries—or to the presence of the working group on surgical endocrinology (CAEK) of the German society for general and visceral surgery (DGAV)—and to assess the adherence to current international treatment guidelines. Methods: An analysis of the preoperative diagnostics, the applied operative techniques and the underlying histological entities was carried out for all operations on adrenal glands in Germany, Switzerland and Austria, which were registered in EUROCRINE® from 2015 to 2019. Results: In the total of 21 participating hospitals from the German-speaking EUROCRINE® countries, 658 operations on adrenal glands were performed. In 90% of cases unilateral adrenalectomy was performed, in 3% bilateral adrenalectomy and in 7% other resection procedures. In 41% the main histological diagnosis was an adrenocortical adenoma. In 15% malignant entities were detected on final histology, including 6% adrenocortical carcinoma (ACC) and 8% metastases to the adrenal glands. 23% of the operations were performed for pheochromocytoma. This entity was primarily resected using minimally invasive approaches (82%), whereas minimally invasive techniques were applied in 28% for ACC and in 66% for metastases to the adrenal glands. Conclusion: Surprisingly, following adrenocortical adenoma and pheochromocytoma, the third most common histological entity was metastasis of different extra-adrenal primary tumors to the adrenal gland. Of the operations for ACC 28% were scheduled for minimally invasive techniques, but conversion to open surgery was necessary in 20%. The analysis revealed discrepancies between treatment reality and international guideline recommendations that raise questions, which will be addressed by an updated version of the EUROCRINE® module for the documentation of adrenal surgery.

References Powered by Scopus

Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey

25777Citations
N/AReaders
Get full text

Combination chemotherapy in advanced adrenocortical carcinoma

675Citations
N/AReaders
Get full text

The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas.

218Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Volume-outcome relationship for adrenalectomy: analysis of an administrative dataset for the Getting It Right First Time Programme

22Citations
N/AReaders
Get full text

Outcomes after surgical treatment of metastatic disease in the adrenal gland; valuable for the patient?

10Citations
N/AReaders
Get full text

Adrenal Surgery in the Era of Multidisciplinary Endocrine Tumor Boards

2Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Staubitz, J. I., Clerici, T., Riss, P., Watzka, F., Bergenfelz, A., Bareck, E., … Musholt, T. J. (2021). EUROCRINE®: adrenal surgery 2015–2019— surprising initial results. Chirurg, 92(5), 448–463. https://doi.org/10.1007/s00104-020-01277-6

Readers over time

‘21‘22‘23‘2402468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

67%

Professor / Associate Prof. 1

17%

Researcher 1

17%

Readers' Discipline

Tooltip

Medicine and Dentistry 9

100%

Save time finding and organizing research with Mendeley

Sign up for free
0